I just put it in Google translator, and this is what it said (likely some translation errors):
PuraMed Bioscience (WKN: A0NJHP ) is serious : After months of silence , the small pharmaceutical company now wants to give the go-ahead for an investor offensive ! According SD information PuraMed receives today from 20 Clock German time post at Oxford City Broadcasting Network . In addition, the currently ongoing preparation of a corporate message has been confirmed to us on request. But that is only the beginning: As the last quarter report reveals PuraMed want from next month due to start so right and put a large marketing campaign in gear to finally make known his migraine product LipiGesic M . So there is talk of a " aggressive implementation of web presence and social marketing ." An Amazon project should start as early as this month. In addition, to be introduced in the second quarter newsletter for customers and investors.
Even more news !
It is therefore to be assumed that in the short term , a number of news around PuraMed run across the ticker. "We expect to publish soon some news regarding a number of initiatives ," it said in a statement provided to us by the Company . It is possible that PuraMed could gain new distribution partner for the meantime . Using appropriate , intensive negotiations - also internationally - was informed in the last filing. PuraMeds flagship has proven a unique position in that it is more effective than most expensive , prescription medicines and can be taken as a powder, not liquid. In addition, it is the only clinically tested " over-the -counter " migraine product in which not the typical side effects were noted. Besides LipiGesic M PuraMed has two other products from the LipiGesic series against headache and sleeping in the pipeline, planned for launch after the successful commercialization of the first album . PuraMeds share price lost in the wake of missing sales and news last year about 98 % of its value . From his last year's February high the paper is currently a whopping 3,000 % removed. In view of the forthcoming publications is now an entry as a very lucrative speculation could prove .
Declaration pursuant to § 34b para 1 of the Securities Trading Act
The author declares itself to be in possession of the financial instrument discussed herein and may sell this at any time. Thus, there is the possibility of a conflict of interest.
PMBS
All of my posts are in my opinion only, formulated from the publicly available data and information, and are not meant to be investment advice in any shape or form...
